Last reviewed · How we verify
NCT04600037
Pregabalin Treatment for Trigger Points
NA trial testing Pregabalin 150mg in Myofascial Pain Syndrome in 40 participants. Completed in 26 January 2015.
26 July 2014
Quick facts
| Lead sponsor | Fatih Sultan Mehmet Training and Research Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 40 |
| Start date | 26 April 2014 |
| Primary completion | 26 July 2014 |
| Estimated completion | 26 January 2015 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Pregabalin 150mg — full drug profile →
Conditions studied
- Myofascial Pain Syndrome — all drugs for Myofascial Pain Syndrome →
Sponsor
Fatih Sultan Mehmet Training and Research Hospital
Who can join
Adults 18 to 65, female only, with Myofascial Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Myofascial pain syndrome (MPS) is a common problem in the general population. MPS should not be a local/peripheral painful syndrome and considered to be a syndrome of central sensitivity. We aimed to investigate the effect of pregabalin in patients with MPS in this study
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effectiveness of pregabalin treatment for trigger points in patients with comorbid myofascial pain syndrome and fibromyalgia syndrome: a randomized controlled trial.
Karamanlioglu DS, Geler Kulcu D, Ozturk G, Akpinar P, et al · · 2021 · cited 5× · PMID 34544324 · DOI 10.1080/08990220.2021.1977265
Verify or expand the search:
- PubMed search for NCT04600037
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Pregabalin 150mg
Trials testing the same drug.
- NCT05704374 — The Effect of Sympathetic Dysfunction on Muscle Spindle in Fibromyalgia · NA · unknown
- NCT04666714 — Efficacy and Safety of Praga Formulation in the Treatment of Neuropathic Pain · Phase 3 · recruiting
- NCT05804591 — Pregabalin in the Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy (LSG). · Phase 4 · recruiting
- NCT05763550 — To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Herpetic Neuralgia · Phase 2 · completed
- NCT05598905 — Combined Effect of Pregabalin and Oxycodone, and Lacosamide and Oxycodone, on Breathing · Phase 4 · completed
Other recruiting trials for Myofascial Pain Syndrome
Currently open trials in the same condition.
- NCT07511751 — COMPARISON OF THREE TREATMENT MODALITIES İN MYOFASCIAL PAIN SYNDROME · NA · recruiting
- NCT07045324 — Effect of Vagus Nerve Stimulation on Trapezius Trigger Point · NA · active not recruiting
Other Fatih Sultan Mehmet Training and Research Hospital trials
Trials by the same sponsor.
- NCT07589582 — Active Noise-Cancelling Headphones Reduce Operative Time and Improve Procedural Consistency in ACL Reconstruction l · NA · active not recruiting
- NCT07523828 — Laryngeal Edema Assessment by Cuff Leak Test and Ultrasound in ICU Patients and Its Relationship With Weaning Success · not yet recruiting
- NCT07487038 — The Efficacy and Safety of a Single-Dose Hyaluronic Acid Injection in the Treatment of Knee Osteoarthritis · not yet recruiting
- NCT07485465 — Lymphoedema Diagnosis and Treatment · not yet recruiting
- NCT07451925 — Prediction of Postoperative Pain Using Venous Cannulation Pain and Preoperative Anxiety Scores · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04600037 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fatih Sultan Mehmet Training and Research Hospital
- Last refreshed: 23 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04600037.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing